Renzo Canetta, M.D.
Renzo Canetta graduated from the University of Milan, Italy, and is Board-certified in Clinical and Laboratory Hematology. He worked at the Istituto Nazionale Tumori in Milan, Italy, from 1974 to 1980, and his research focus was on clinical trials in lymphomas and gastrointestinal tumors. Since joining Bristol-Myers Squibb (BMS) in 1980, Dr. Canetta has held numerous roles of increasing responsibility and leadership, including Head of Clinical Cancer Research; Head of Development, Life Cycle Management; and currently as Vice President, Oncology Global Clinical Research. His experience can be best summarized by the clinical development leading to the acceptance by Health Authorities and the introduction to the medical practice of 14 new anticancer agents and 2 new anti-viral drugs. His area of expertise relates to cancer patient care, diagnosis, and experimental treatment of hematologic malignancies and solid tumors, methodology of clinical trials, and new drug development.